Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Support

This activity is supported by an educational grant from Bayer Healthcare Pharmaceuticals Inc.

Patient, Provider, & Caregiver Connection™: Working Together to Improve Patient Outcomes in PAH

Release Date: June 30, 2021
Expiration Date: June 30, 2022

Activity Overview

This video-based program is designed for health care professionals to explore the diagnosis and treatment of pulmonary arterial hypertension (PAH) through a unique perspective, putting the patient voice front and center. A patient and their caregiver will lend their expertise to this program by sharing their journey living with PAH. This online activity focuses on the complex disease pathophysiology and etiology of PAH, the clinical presentation and diagnostic approach, the efficacy and safety data of available therapies, and best practices for treatment of PAH.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Bayer Healthcare Pharmaceuticals Inc.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This educational activity is directed toward pulmonologists, cardiologists, primary care clinicians, nurse practitioners, physician assistants, and other health care professionals involved in the management of patients with PAH.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Identify patients at risk of developing PAH
  • Describe the diagnostic approach to PAH based on clinical presentation and other factors
  • Evaluate the latest clinical efficacy and safety data for current and emerging therapeutic agents for the treatment of patients with PAH
  • Customize individualized treatment plans to address patients’ PAH-related burden using shared decision-making

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.


Victor Tapson, MD
Victor Tapson, MD
Professor of Medicine
Associate Director, Division of Pulmonary and Critical Care
Director, Pulmonary Vascular Disease Research
Cedars-Sinai Medical Center
Los Angeles, CA

Disclosures: Grant/Research Support: Actelion, Bayer, Janssen, Johnson & Johnson, United Therapeutics; Consultant: Actelion, Bayer, Janssen, Johnson & Johnson, United Therapeutics; Speaker’s Bureau: Janssen.

Vallerie McLaughlin, MD
Vallerie McLaughlin, MD
Kim A. Eagle MD Endowed Professor of Cardiovascular Medicine
Director of the Pulmonary Hypertension Program
University of Michigan
Ann Arbor, MI

Disclosures: Grant/Research Support: Acceleron Pharma, Actelion, Reata Pharmaceuticals, Sanofi, United Therapeutics; Consultant: Acceleron Pharma, Actelion, Aerovate Therapeutics, Bayer, Caremark, Gossamer-Bio, Merck, United Therapeutics.

Nicole Kim

Disclosures: Nicole Kim has no relevant financial relationships with ineligible companies.

Jamie Yoo

Disclosures: Jamie Yoo has no relevant financial relationships with ineligible companies.

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By